Swine Flu: PROBLEM with vaccination

Now, we have a problem with release a Swine Flu vaccine in USA, Canada and other country worldwide. Read the shot news about it:
Via CBCnews.ca: Address swine flu vaccine fears, doctor urges. Excerpt: "...Some Canadians at high risk of getting swine flu have said they don't trust the vaccine enough to get the shot. ... Pregnant women, health-care workers, those living in northern and remote communities and people under age 65 with chronic health conditions are expected to be targeted first when the vaccine is released in Canada in November.

U.S. Health and Human Services Secretary Kathleen Sebelius recently told ABC's George Stephanopoulos that the swine flu vaccine will be available in the United States by the first week of October, 2 weeks earlier than has been previously expected.

A YouTube video of Dr. Girard being interviewed on French television about this is below, but unless you know French you will not be able to understand it. For those that don't speak French, the following is a translation of the most pertinent portion of his remarks:

A vaccine is being developed in conditions of amateurism such as I have never seen. Lets take the pessimistic hypothesis: one death among every 1000 patients. There are plans to vaccinate 60 million people, and you so you already have 60,000 deaths, and this time, young people, children, pregnant women.

By: MARILYNN MARCHIONE, Associated Press: Novel flu drug proves effective; Tamiflu saves lives, not just shortens illness, studies show."...Several other studies showed the value of treatment with Tamiflu. In one study of hundreds of people stricken with bird flu around the world, half of those given Tamiflu survived, while nearly 90 percent of those not given flu medicines died. Other research showed Tamiflu improved survival from regular seasonal flu, too..."

Tamiflu, made by Swiss-based Roche Holding AG, and Relenza, made by British-based GlaxoSmithKline, came on the market in 1999. Most people who get swine flu don't need them, but these drugs can help save the severely ill, studies sponsored by Tamiflu's maker suggest.